Skip to content
TrialScanner

NCT03978624

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Phase 2Active, not recruitingSNDXCollaboratorMRKCollaborator

Registry record

Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Conditions
Bladder Cancer
Primary completion
Mar 25, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03978624 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03978624: Window of Opportunity Study... | TrialScanner